Borovskaya T G, Krivova N A, Zaeva O B, Fomina T I, Kamalova S I, Poluektova M E, Vychuzhanina A V, Shchemerova Yu A, Grigor'eva V A, Goldberg V E, Plotnikov M B
E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia,
Bull Exp Biol Med. 2015 Feb;158(4):513-6. doi: 10.1007/s10517-015-2797-9. Epub 2015 Feb 24.
A course of dihydroquercetin (antioxidant) injections to 5-month-old Wistar rats with sulpiride-induced benign prostatic hyperplasia led to reduction of proliferative activity in the glandular structures and to attenuation of the inflammatory reaction in the tissue. Prostatic antioxidant/prooxidant balance returned to normal after the treatment.